Rkl Wealth Management LLC Bristol Myers Squibb CO Transaction History

Rkl Wealth Management LLC

$1.1 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$47.98 - $54.4 $1.64 Million - $1.87 Million	-34,284 Reduced 82.51%	7,269 $394,000
Q4 2023 Jan 24, 2024	BUY	$48.48 - $57.85 $296,164 - $353,405	6,109 Added 17.24%	41,553 $2.13 Million
Q3 2023 Nov 03, 2023	SELL	$57.89 - $64.73 $26,687 - $29,840	-461 Reduced 1.28%	35,444 $2.06 Million
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $8,855 - $9,832	139 Added 0.39%	35,905 $2.3 Million
Q1 2023 May 01, 2023	SELL	$65.71 - $74.53 $12,682 - $14,384	-193 Reduced 0.54%	35,766 $2.48 Million
Q4 2022 Feb 06, 2023	BUY	$68.48 - $81.09 $8,423 - $9,974	123 Added 0.34%	35,959 $2.59 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $7 - $4,533	-59 Reduced 0.16%	35,836 $2.55 Million
Q2 2022 Aug 01, 2022	BUY	$72.62 - $79.98 $46,549 - $51,267	641 Added 1.82%	35,895 $2.76 Million
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $44,695 - $53,594	727 Added 2.11%	35,254 $2.58 Million
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $40,329 - $47,015	752 Added 2.23%	34,527 $2.15 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $35,383 - $41,447	-598 Reduced 1.74%	33,775 $2 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $59,681 - $64,992	964 Added 2.89%	34,373 $2.3 Million
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $136,482 - $153,502	-2,300 Reduced 6.44%	33,409 $2.11 Million
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $8,545 - $9,683	-148 Reduced 0.41%	35,709 $2.22 Million
Q3 2020 Nov 09, 2020	SELL	$57.43 - $63.64 $1,780 - $1,972	-31 Reduced 0.09%	35,857 $2.16 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $57,780 - $67,550	1,054 Added 3.03%	35,888 $2.11 Million
Q1 2020 Apr 28, 2020	SELL	$46.4 - $67.43 $39,950 - $58,057	-861 Reduced 2.41%	34,834 $1.94 Million
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $364,006 - $474,813	7,397 Added 26.14%	35,695 $2.29 Million
Q3 2019 Oct 31, 2019	BUY	$42.77 - $50.71 $60,605 - $71,856	1,417 Added 5.27%	28,298 $1.43 Million
Q2 2019 Aug 02, 2019	SELL	$44.62 - $49.34 $53,499 - $59,158	-1,199 Reduced 4.27%	26,881 $1.22 Million
Q1 2019 Apr 26, 2019	BUY	$45.12 - $53.8 $46,067 - $54,929	1,021 Added 3.77%	28,080 $1.34 Million
Q4 2018 Feb 08, 2019	SELL	$48.76 - $63.23 $1,023 - $1,327	-21 Reduced 0.08%	27,059 $1.41 Million
Q3 2018 Nov 07, 2018	BUY	$55.19 - $62.25 $15,784 - $17,803	286 Added 1.07%	27,080 $1.68 Million
Q2 2018 Aug 03, 2018	SELL	$50.53 - $62.98 $74,784 - $93,210	-1,480 Reduced 5.23%	26,794 $1.48 Million
Q1 2018 Apr 26, 2018	BUY	$59.92 - $68.98 $104,440 - $120,232	1,743 Added 6.57%	28,274 $1.79 Million
Q4 2017 Feb 02, 2018	SELL	$59.94 - $65.35 $7,192 - $7,841	-120 Reduced 0.45%	26,531 $1.63 Million
Q3 2017 Nov 07, 2017	BUY	$55.23 - $63.74 $168,672 - $194,661	3,054 Added 12.94%	26,651 $1.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	23,597	23,597 $1.31 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.24 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.41 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.54 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.55 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rkl Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rkl Wealth Management LLC with notifications on news.

Account